The defect in the anticoagulation response to APC had been detected as a new mechanism for thrombophilia, which was subsequently linked to a single point mutation on the factor V gene, resulting in Arg506-Gln substitution in the APC cleavage site [12]. The gene discussed is APC; the disease is Rare hereditary thrombophilia.